Abstract:New thalidomide analogs have been designed and synthesized by hybridizing the immunomodulatory gutarimide moiety with three antiproliferative nuclei: quinazolinedione, phthalazinedione, and quinoxalinone. The biological results revealed the strong impact of quinazoline derivatives 7a and 28, and phthalazine based 20a against HepG‐2, MCF‐7, PC3, and HCT‐116 cell lines, compared to thalidomide. In particular, compound 20a was the most promising as it had far better biological activity than thalidomide with regard to inhibition of TNF‐α, IL‐6, caspase 3, COX‐I/II, and VEGFR‐2, as well as cell cycle arrest, and apoptosis rate enhancement in MCF‐7 cells, the most sensitive cell line to the current new molecules. Compound 20a caused reduction in levels of TNF‐α and IL‐6 by 75.22% and 82.51%, respectively. It elevated the caspase‐3 level by 7.21‐fold. Furthermore, IC50 against COX‐I, COX‐II, and VEGFR‐2 were 0.65 μM, 0.33 μM, and 232 nM, respectively. In addition, it raised the apoptosis rate from 65.65% to 99.89%. Moreover, 20a was further examined through a docking study and a 200 ns molecular dynamics simulation for its complex with VEGFR‐2, along with computational ADME properties. This work suggests the high significance of compounds 20a, 7a and 28, as lead compounds for development of new effective immunomodulatory antitumor drugs.

Synthesis and Biological Evaluation of Novel Thalidomide Analogues As Potential Anticancer Drugs

Synthesis and biological evaluation of nitric oxide-donating thalidomide analogues as anticancer agents.

Synthesis and Bioactivity of Novel Phthalimide Derivatives

Synthesis and Primary Anti-tumor Activities of 3-Fluoro-or 3-Amino-6-substituted-5,6-dihydropyrrolo [3,4-b] pyridin-7-ones

Discovery of New Immunomodulatory Anticancer Thalidomide Analogs: Design, Synthesis, Biological Evaluation and In Silico Studies

Synthesis and Cytotoxic Evaluation of Novel Dimethyl [1,1′‐biphenyl]‐2,2′‐dicarboxylates Bearing 1,3,4‐thiadiazole Moieties

Synthesis and Antiproliferative Activity of Novel 1,3,4-Thiadiazole Derivatives

New immunomodulatory anticancer quinazolinone-based thalidomide analogs: design, synthesis and biological evaluation

Synthesis and biological evaluation of novel podophyllotoxin analogs as antitumor agents.

Synthesis, Molecular Docking and Antitumor Activity of New Dithiazoles

Synthesis And Biological Evaluation Of Novel Benzothiazole-2-Thiol Derivatives As Potential Anticancer Agents

Synthesis and Antitumor Activity Evaluation of Novel 2-Amino-5-ethylpyrimidine Derivatives

Synthesis and Biological Evaluation of Thalidomide Derivatives as Potential Anti-Psoriasis Agents

Synthesis and molecular docking of some new thiazolidinone and thiadiazole derivatives as anticancer agents

Synthesis and Antiproliferative Activity of New Thiosemicarboxamide Derivatives

Synthesis, Biological Evaluation and Molecular Modeling of 1,3,4-Thiadiazol-2-amide Derivatives As Novel Antitubulin Agents.

Synthesis and Biological Activities of 3-Methoxy-6-substituted-5,6-dihydropyrrolo[3,4-b]pyridin-7-ones

Synthesis, Structure-Activity Relationships and Preliminary Antitumor Evaluation of Benzothiazole-2-Thiol Derivatives As Novel Apoptosis Inducers

Synthesis and Cytotoxic Evaluation of New Colchicine Derivatives Bearing 1,3,4-Thiadiazole Moieties

Synthesis and Anti-tumor Activity of Novel 2-Amino-1,3,4-thiadiazole Derivativers

Synthesis, Antitumor and Antimicrobial Evaluation of Novel 1,3,4-Thiadiazole Derivatives Bearing Disulfide Bond